Historial del iniciado Otro Rendimiento medio T+90
+8.8%
Sobre 20 señales de compra con un rendimiento T+90 consolidado. Base de rendimiento: cierre del día siguiente a la publicación.
Browse the detailed record of transactions filed by Dr Hal Barron. Officer active across 1 company, notably GSK plc. Cumulatively, 66 reports have been recorded. History available since 20 June 2023. The latest transaction was disclosed on 10 July 2026 (Purchase). Regulator: RNS (LSE). The full history is openly available.
Companies and markets linked to Dr Hal Barron Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declaraciones 66 en total
● Non-Executive Director · Directivos · 10 jul 2026 · GSK plc 28 títulos @ 52,7354 GBP New York Stock Exchange (XNYS)ISIN ISIN US37733W2044RNS:9673287-6 ● Non-Executive Director · Directivos · 10 jul 2026 · GSK plc 28 títulos @ 0,5275 GBP 0.0000% mcap 0.0% de su flujo New York Stock Exchange (XNYS)ISIN ISIN US37733W2044RNS:68763dee-a518-4ccc-8d25-48330cbfa37e-6 ● Non-Executive Director · Directivos · 15 may 2026 · GSK plc 74 títulos @ 0,4968 GBP 0.0000% mcap 0.1% de su flujo New York Stock Exchange (XNYS)ISIN ISIN US37733W2044RNS:71bad38c-0929-4edd-b15e-28516b69c2b2 ● Non-Executive Director · Directivos · 15 may 2026 · GSK plc 74 títulos @ 49,67 GBP 0.0000% mcap 100.0% de su flujo New York Stock Exchange (XNYS)ISIN ISIN US37733W2044RNS:9578478 ● Non-Executive Director · Directivos · 9 abr 2026 · GSK plc 26 títulos @ 0,5892 GBP 0.0000% mcap 0.0% de su flujo New York Stock Exchange (XNYS)ISIN ISIN US37733W2044RNS:ca89baf1-aabf-4020-b0fe-d5c65c1b3a57-12 ● Non-Executive Director · Directivos · 20 feb 2026 · GSK plc 64 títulos @ 0,5952 GBP 0.1% de su flujo New York Stock Exchange (XNYS)ISIN ISIN US37733W2044RNS:1775c9bd-4348-4ec9-b09c-470ab0585b57 ● Non-Executive Director · Directivos · 14 ene 2026 · GSK plc 0
New York Stock Exchange (XNYS)ISIN ISIN US37733W2044RNS:2a8cdbd4-1f4a-4a5f-a33e-d0463dade4dc-0 ● Non-Executive Director · Directivos · 9 ene 2026 · GSK plc 28 títulos @ 0,5043 GBP 0.0% de su flujo New York Stock Exchange (XNYS)ISIN ISIN US37733W2044RNS:07b8fade-09b6-4441-a582-c78ac4e1b6b3-36 ● Non-Executive Director · Directivos · 14 nov 2025 · GSK plc 69 títulos @ 0,4717 GBP 0.1% de su flujo New York Stock Exchange (XNYS)ISIN ISIN US37733W2044RNS:32cbdf7b-559f-4c56-829b-a5f4769c98f9-1 ● Non-Executive Director · Directivos · 14 oct 2025 · GSK plc 0
New York Stock Exchange (XNYS)ISIN ISIN US37733W2044RNS:5864301-0 ● Non-Executive Director · Directivos · 10 oct 2025 · GSK plc 28 títulos @ 0,4375 GBP 0.0% de su flujo New York Stock Exchange (XNYS)ISIN ISIN US37733W2044RNS:5859068-27 ● Non-Executive Director · Directivos · 19 sept 2025 · GSK plc 240 títulos @ 0,4074 GBP 0.3% de su flujo New York Stock Exchange (XNYS)ISIN ISIN US37733W2044RNS:5830475-3 ● Non-Executive Director · Directivos · 15 ago 2025 · GSK plc 84 títulos @ 0,3936 GBP 0.1% de su flujo New York Stock Exchange (XNYS)ISIN ISIN US37733W2044RNS:5786546-1 ● Non-Executive Director · Directivos · 17 jul 2025 · GSK plc 0
New York Stock Exchange (XNYS)ISIN ISIN US37733W2044RNS:5744703-0 ● Non-Executive Director · Directivos · 11 jul 2025 · GSK plc 30 títulos @ 0,3853 GBP 0.0% de su flujo New York Stock Exchange (XNYS)ISIN ISIN US37733W2044RNS:5737340-34 ● Non-Executive Director · Directivos · 20 jun 2025 · GSK plc 258 títulos @ 0,379 GBP 0.3% de su flujo New York Stock Exchange (XNYS)ISIN ISIN US37733W2044RNS:5708028-4 ● Non-Executive Director · Directivos · 20 jun 2025 · GSK plc 258 títulos @ 0,379 GBP 0.3% de su flujo New York Stock Exchange (XNYS)ISIN ISIN US37733W2044RNS:5707630-4 ● Non-Executive Director · Directivos · 16 may 2025 · GSK plc 87 títulos @ 0,3764 GBP 0.1% de su flujo New York Stock Exchange (XNYS)ISIN ISIN US37733W2044RNS:5661771-1 ● Non-Executive Director · Directivos · 15 abr 2025 · GSK plc 0
New York Stock Exchange (XNYS)ISIN ISIN US37733W2044RNS:5622701-13 ● Non-Executive Director · Directivos · 11 abr 2025 · GSK plc 29 títulos @ 0,3414 GBP 0.0% de su flujo New York Stock Exchange (XNYS)ISIN ISIN US37733W2044RNS:5617047-2 ● Non-Executive Director · Directivos · 20 mar 2025 · GSK plc 249 títulos @ 0,3927 GBP 0.3% de su flujo New York Stock Exchange (XNYS)ISIN ISIN US37733W2044RNS:5584787-4 ● Non-Executive Director · Directivos · 21 feb 2025 · GSK plc 83 títulos @ 0,3664 GBP 0.1% de su flujo New York Stock Exchange (XNYS)ISIN ISIN US37733W2044RNS:5553317-1 ● Non-Executive Director · Directivos · 18 feb 2025 · GSK plc 45.690 títulos 0
N/AISIN ISIN US37733W2044RNS:5546603-2 ● Non-Executive Director · Directivos · 18 feb 2025 · GSK plc 24.623 títulos @ 0,3664 GBP 26.5% de su flujo New York Stock Exchange (XNYS)ISIN ISIN US37733W2044RNS:5546603-3 ● Non-Executive Director · Directivos · 14 ene 2025 · GSK plc 0
New York Stock Exchange (XNYS)ISIN ISIN US37733W2044RNS:5502203-14 25 de 66 declaraciones
Ver más (41 restantes) About Dr Hal Barron Dr Hal Barron has filed 64 declarations in total. As Non-Executive Director of GSK plc, his 64 sampled filings, covering the period from 2023-06-23 to 2026-05-20, show purchases of EUR 5941 and sales of EUR 34332, with the modal transaction nature listed as Purchase.